{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T23:22:50Z","timestamp":1780788170381,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":196,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrition"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.nut.2012.07.006","type":"journal-article","created":{"date-parts":[[2012,11,13]],"date-time":"2012-11-13T02:48:07Z","timestamp":1352774887000},"page":"178-183","source":"Crossref","is-referenced-by-count":144,"title":["Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: Effects on lipid profiles, inflammation markers, and quality of life"],"prefix":"10.1016","volume":"29","author":[{"given":"Constantin","family":"Militaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionut","family":"Donoiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Craciun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulia Daria","family":"Scorei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca Mihaela","family":"Bulearca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romulus Ion","family":"Scorei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nut.2012.07.006_bib1","first-page":"545","article-title":"Future cardiovascular endpoint studies: where will the research take us?","volume":"84","author":"LaRosa","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nut.2012.07.006_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1373\/clinchem.2007.097360","article-title":"Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction","volume":"54","author":"Ren\u00e9","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.nut.2012.07.006_bib3","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1089\/jmf.2007.0091","article-title":"Beneficial effects of resveratrol on atherosclerosis","volume":"11","author":"Fan","year":"2008","journal-title":"J Med Food"},{"key":"10.1016\/j.nut.2012.07.006_bib4","doi-asserted-by":"crossref","first-page":"H1988","DOI":"10.1152\/ajpheart.01012.2001","article-title":"Pharmacological preconditioning with resveratrol: role of nitric oxide","volume":"282","author":"Hattori","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.nut.2012.07.006_bib5","doi-asserted-by":"crossref","first-page":"H2138","DOI":"10.1152\/ajpheart.00852.2006","article-title":"Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol","volume":"292","author":"Juric","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.nut.2012.07.006_bib6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/HYPERTENSIONAHA.109.133397","article-title":"Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats","volume":"54","author":"Csiszar","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.nut.2012.07.006_bib7","doi-asserted-by":"crossref","first-page":"H985","DOI":"10.1152\/ajpheart.00489.2010","article-title":"Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative\/nitrative stress","volume":"299","author":"Zhang","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.nut.2012.07.006_bib8","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1124\/jpet.107.127548","article-title":"Effects of\u00a0resveratrol (trans-3,5,4-trihydroxystilbene) treatment on cardiac remodeling following myocardial infarction","volume":"323","author":"Burstein","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nut.2012.07.006_bib9","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1124\/dmd.104.000885","article-title":"High absorption but very low bioavailability of oral resveratrol in humans","volume":"32","author":"Walle","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.nut.2012.07.006_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/2156587211407638","article-title":"Growing evidence for human health benefits of boron","volume":"16","author":"Nielsen","year":"2011","journal-title":"J Evid Based Complement Alternat Med"},{"key":"10.1016\/j.nut.2012.07.006_bib11","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s12011-011-8972-6","article-title":"Calcium fructoborate\u2014potential anti-inflammatory agent","volume":"143","author":"Scorei","year":"2011","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.nut.2012.07.006_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tca.2010.04.006","article-title":"Thermal analysis of a calcium fructoborate sample","volume":"506","author":"Rotaru","year":"2010","journal-title":"Thermochim Acta"},{"key":"10.1016\/j.nut.2012.07.006_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12011-007-0019-7","article-title":"In\u00a0vitro effects of calcium fructoborate on fMLP stimulated human neutrophil granulocytes","volume":"118","author":"Scorei","year":"2007","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.nut.2012.07.006_bib14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12011-009-8488-5","article-title":"In\u00a0vitro effects of calcium fructoborate upon production of inflammatory mediators by LPS-stimulated RAW 264.7 macrophages","volume":"135","author":"Scorei","year":"2010","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.nut.2012.07.006_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12011-011-9083-0","article-title":"A double-blind, placebo-controlled pilot study to evaluate the effect of calcium fructoborate on systemic inflammation and dyslipidemia markers for middle-aged people with primary osteoarthritis","volume":"144","author":"Scorei","year":"2011","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.nut.2012.07.006_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5099\/aj120200111","article-title":"Short-term intake of calcium fructoborate improves WOMAC and McGill scores and beneficially modulates biomarkers associated with knee osteoarthritis: a pilot clinical double-blinded placebo-controlled study","volume":"4","author":"Reyes-Izquierdo","year":"2012","journal-title":"Am J Biomed Sci"},{"key":"10.1016\/j.nut.2012.07.006_bib17","unstructured":"Mitrut P, Burada F, Rogoz I, Genunche-Dumitrescu A. Experimental studies in\u00a0vivo regarding the effect of resveratrol extracted from vine on gastric neoplastic injuries. Unpublished data. Romanian grant 954\/2007, type A CNCSIS. 2007\u20132009."},{"key":"10.1016\/j.nut.2012.07.006_bib18","unstructured":"European Union 2002. 2002\/72\/CE Commission directive of 6 August 2002\u00a0relating to plastics materials intended to come into contact with plastics, Official Journal of European Communities, nr. L220 of 15.08.2002, p.18."},{"key":"10.1016\/j.nut.2012.07.006_bib19","series-title":"The health professional's guide to dietary supplements","author":"Talbott","year":"2006"},{"key":"10.1016\/j.nut.2012.07.006_bib20","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1158\/1055-9965.EPI-07-0022","article-title":"Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent","volume":"16","author":"Boocock","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.nut.2012.07.006_bib21","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","article-title":"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial","volume":"295","author":"Nissen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.nut.2012.07.006_bib22","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/0002-9149(94)90555-X","article-title":"Monitoring the quality of life in patients with coronary heart disease","volume":"74","author":"Spertus","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nut.2012.07.006_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","article-title":"Development and evaluation of the Seattle Anginal Questionnaire: a new functional status measure for coronary artery disease","volume":"25","author":"Spertus","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nut.2012.07.006_bib24","doi-asserted-by":"crossref","first-page":"III-20","DOI":"10.1161\/01.CIR.0000131514.71167.2e","article-title":"Inflammation in atherosclerosis and implications for therapy","volume":"109","author":"Paoletti","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.nut.2012.07.006_bib25","doi-asserted-by":"crossref","unstructured":"DeJongste MJL, A Tio R, D Foreman R. Chronic therapeutically refractory angina pectoris. Heart 2004;90:225\u201330.","DOI":"10.1136\/hrt.2003.025031"},{"key":"10.1016\/j.nut.2012.07.006_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/act.1998.4.333","article-title":"Dietary and lifestyle interventions for a healthy heart","volume":"4","author":"Meletis","year":"1998","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.nut.2012.07.006_bib27","series-title":"UpToDate","article-title":"Nutritional antioxidants in coronary heart disease","author":"Tangney","year":"2008"},{"key":"10.1016\/j.nut.2012.07.006_bib28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/19390210903070772","article-title":"Calcium fructoborate: plant-based dietary boron for human nutrition","volume":"6","author":"Miljkovic","year":"2009","journal-title":"J Diet Suppl"},{"key":"10.1016\/j.nut.2012.07.006_bib29","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbrc.2007.12.138","article-title":"Molecular mechanisms of oxidative stress resistance induced by resveratrol: specific and progressive induction of MnSOD","volume":"367","author":"Robb","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nut.2012.07.006_bib30","first-page":"1","article-title":"Opinion of the scientific panel on dietetic products, nutrition and allergies on a request from the commission related to the tolerable upper intake level of boron (sodium borate and boric acid)","volume":"80","author":"EFSA","year":"2004","journal-title":"EFSA J"},{"key":"10.1016\/j.nut.2012.07.006_bib31","unstructured":"USEPA (2004) Toxicological review of boron and compounds. (CAS No. 7440-42-8) In Support of Summary Information on the Integrated Risk Information System (IRIS) EPA 635\/04\/052 www.epa.gov\/iris US Environmental Protection Agency, Washington D.C. June 2004."},{"key":"10.1016\/j.nut.2012.07.006_bib32","first-page":"211","article-title":"Dietary boron affects blood cell counts and hemoglobin concentrations in humans","volume":"4","author":"Nielsen","year":"1991","journal-title":"J Trace Elem Exp Med"},{"key":"10.1016\/j.nut.2012.07.006_bib33","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1016\/S0021-9258(18)53458-X","article-title":"In\u00a0vitro and in\u00a0vivo characterization of a neutral boron-containing thrombin inhibitor","volume":"268","author":"Tapparelli","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nut.2012.07.006_bib34","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jtemb.2009.03.001","article-title":"Boron deprivation decreases liver S-adenosylmethionine and spermidine and increases plasma homocysteine and cysteine in rats","volume":"23","author":"Nielsen","year":"2009","journal-title":"J Trace Elem Med Biol"},{"key":"10.1016\/j.nut.2012.07.006_bib35","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1093\/jn\/133.11.3577","article-title":"Dietary boron decreases peak pancreatic in situ insulin release in chicks and plasma insulin concentrations in rats regardless of vitamin D or magnesium status","volume":"133","author":"Bakken","year":"2003","journal-title":"J Nutr"},{"key":"10.1016\/j.nut.2012.07.006_bib36","first-page":"61","article-title":"The value of (NT-pro) BNP in the diagnosis, prognosis and treatment of congestive heart failure","volume":"12","author":"van Kimmenade","year":"2004","journal-title":"Neth Heart J"},{"key":"10.1016\/j.nut.2012.07.006_bib37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/hrt.2009.187179","article-title":"C-reactive protein for risk assessment in coronary artery disease","volume":"96","author":"Danchin","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.nut.2012.07.006_bib38","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1172\/JCI115146","article-title":"Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide","volume":"87","author":"Mukoyama","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nut.2012.07.006_bib39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijcard.2009.10.035","article-title":"NT-pro-BNP is associated with inducible myocardial ischemia in mildly symptomatic type 2 diabetic patients","volume":"145","author":"Wiersma","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.nut.2012.07.006_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4070\/kcj.2011.41.2.61","article-title":"Effect of valsartan on N-terminal pro-brain natriuretic peptide in patient with stable chronic heart failure: comparison with enalapril","volume":"41","author":"Lee","year":"2011","journal-title":"Korean Circ J"}],"container-title":["Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089990071200278X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089990071200278X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T05:43:45Z","timestamp":1643607825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089990071200278X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S089990071200278X"],"URL":"https:\/\/doi.org\/10.1016\/j.nut.2012.07.006","relation":{},"ISSN":["0899-9007"],"issn-type":[{"value":"0899-9007","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}